HF
CTOR

HRT Financial’s Citius Oncology CTOR Stock Holding History

HRT Financial’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-68,543
Closed -$78K – 3558
2024
Q4 		$78K Buy
+68,543
New +$77K ﹤0.01% 2065

Other funds holding CTOR

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's CTOR Position: Q1 2025 in Review

HRT Financial sold out of Citius Oncology (CTOR) in Q1 2025, closing a stake of 68,543 shares — an estimated $78K sold.

HRT Financial first reported a position in CTOR in Q4 2024 and held it in 1 quarter. The position peaked at $78K in Q4 2024. 6 funds tracked by Wall St. Rank hold CTOR as of Q1 2025.

  • HRT Financial reported no remaining Citius Oncology position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 68,543 Citius Oncology shares in Q1 2025, an estimated $78K.
  • HRT Financial first reported a position in Citius Oncology in Q4 2024 and held it in 1 quarter.
  • HRT Financial's Citius Oncology position peaked at $78K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.